Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 4 Thoracic 2 Sarcoma 1 Lymphoid 1 Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1

Interventions

Paclitaxel 35 Bevacizumab 31 Carboplatin 29 pembrolizumab 25 Specimen Handling 20 Magnetic Resonance Spectroscopy 18 olaparib 16 Cisplatin 15 liposomal doxorubicin 13 Taxes 12 Immunoglobulin G 11 Gemcitabine 11 Disulfides 11 Topotecan 9 Nivolumab 9 Cyclophosphamide 9 Biopsy 8 fludarabine 7 Doxorubicin 7 mirvetuximab soravtansine 6 niraparib 5 Radiation 5 Oxaliplatin 5 Fulvestrant 5 Fluorouracil 5 trastuzumab deruxtecan 4 durvalumab 4 cediranib 4 Platinum 4 Megestrol Acetate 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Vinorelbine × Gynecologic × 30 days × Clear all

NCT06459180 2026-05-27

TroFuse-020

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡